Erwin Suh, MD
Ophthalmology · Newark, DENPI 1881636173
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.6% of the total across 27 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 12 manufacturers, the largest accounting for just 23.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $379, 4.6 times the $82 reported in 2019. That places this record below the midpoint for ophthalmology clinicians in DE, where the typical reported total is $1,099.
Across 27 payments — averaging $21.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$133
- Bausch & Lomb Americas Inc.$88
- Tarsus Pharmaceuticals, Inc.$68
- Dompe US, Inc.$62
- Sun Pharmaceutical Industries Inc.$56
- AbbVie$42
- plus $124 from 6 others
What the payments were for
- Food & beverage$55297%
- Gifts$193%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 7 | $133 |
| Bausch & Lomb Americas Inc. | 5 | $88 |
| Tarsus Pharmaceuticals, Inc. | 3 | $68 |
| Dompe US, Inc. | 2 | $62 |
| Sun Pharmaceutical Industries Inc. | 2 | $56 |
| AbbVie(2 entities) | 2 | $42 |
| Mallinckrodt Hospital Products Inc. | 1 | $33 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $20 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Johnson & Johnson Vision Care, Inc. | 1 | $18 |
| Aerie Pharmaceuticals, Inc. | 1 | $17 |
| Kala Pharmaceuticals, Inc. | 1 | $17 |
How this compares
$571 in reported general payments places this provider in the 30th percentile of 49 ophthalmology providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 16 | $14,969 |
| Restasis MultidoseCyclosporine | 18 | $13,051 |
| LumiganBimatoprost | 29 | $11,988 |
| Prednisolone Acetate | 151 | $7,104 |
| Timolol Maleate | 126 | $3,535 |
| Latanoprost | 192 | $2,889 |
| Brimonidine Tartrate | 30 | $2,639 |
| Travoprost | 18 | $2,227 |
| ErythromycinErythromycin Base | 105 | $838 |
| Dorzolamide Hcl | 32 | $782 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 61 | $517 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 30 | $476 |
| Ketorolac Tromethamine | 14 | $262 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Restasis Multidose, Lumigan | $42 | $40,00963 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 30th percentile of 49 ophthalmology providers in Delaware.
Other ophthalmology in Newark
- Jeffrey BoydNewark$2K
- Neil KalinNewark$679
- Neha KumarNewark$290
- David CreechDover$22K
- Bryan SeiffDover$9K
- Jeffrey MinkovitzWilmington$7K
- Heather DealyWilmington$6K
- Stewart SmithWilmington$6K
- David LuDover$5K
- Richard SherryWilmington$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.